Serum concentrations of Erlotinib at a dose of 25 mg daily.
about
Studying clonal dynamics in response to cancer therapy using high-complexity barcoding.EGFR kinase inhibitors and gastric acid suppressants in EGFR-mutant NSCLC: a retrospective database analysis of potential drug interaction.Increased PD-L1 expression in erlotinib-resistant NSCLC cells with MET gene amplification is reversed upon MET-TKI treatment.Association of ABCB1 polymorphisms with erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer.
P2860
Serum concentrations of Erlotinib at a dose of 25 mg daily.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Serum concentrations of Erlotinib at a dose of 25 mg daily.
@ast
Serum concentrations of Erlotinib at a dose of 25 mg daily.
@en
Serum concentrations of Erlotinib at a dose of 25 mg daily.
@nl
type
label
Serum concentrations of Erlotinib at a dose of 25 mg daily.
@ast
Serum concentrations of Erlotinib at a dose of 25 mg daily.
@en
Serum concentrations of Erlotinib at a dose of 25 mg daily.
@nl
prefLabel
Serum concentrations of Erlotinib at a dose of 25 mg daily.
@ast
Serum concentrations of Erlotinib at a dose of 25 mg daily.
@en
Serum concentrations of Erlotinib at a dose of 25 mg daily.
@nl
P2093
P2860
P1476
Serum concentrations of Erlotinib at a dose of 25 mg daily
@en
P2093
Akinobu Hamada
Susumu Kobayashi
Wee-Lee Yeo
P2860
P304
P356
10.1097/JTO.0B013E3181EDF55C
P577
2010-08-01T00:00:00Z